Nasdaq-listed Predictive Oncology launches $344M DePIN treasury focused on Aethir

Predictive Oncology (POAI), a biotech firm known for AI-driven cancer research, has initiated a $344.4 million digital asset treasury focused on Aethir’s ATH token. This venture marks the first instance of a Nasdaq-listed company holding and managing tokens from a Decentralized Physical Infrastructure Network (DePIN). The funding strategy was established with guidance from a Web3 investment and advisory firm and involved two concurrent private placements, integrating cash investments with crypto contributions of ATH tokens. This innovative framework allows Predictive Oncology to list tokenized DePIN infrastructure as a balance sheet asset, connecting traditional equity markets with decentralized computing resources. Following the announcement, shares of Predictive Oncology surged over 70%, reaching highs not seen since March. Previously, the company reported minimal revenue and significant losses, shifting focus after selling its Skyline Medical division to prioritize AI-driven drug discovery. Predictive Oncology’s strategy aligns it with other small-cap firms adopting digital asset treasury models.

Source 🔗